1. Home
  2. QNRX vs AIXI Comparison

QNRX vs AIXI Comparison

Compare QNRX & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$12.25

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

AIXI

XIAO-I Corporation

HOLD

Current Price

$0.62

Market Cap

8.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
QNRX
AIXI
Founded
2018
2001
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
8.9M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
QNRX
AIXI
Price
$12.25
$0.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
154.3K
194.5K
Earning Date
11-06-2025
12-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$70,314,315.00
Revenue This Year
N/A
$26.84
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
18.84
52 Week Low
$5.01
$0.60
52 Week High
$41.80
$6.65

Technical Indicators

Market Signals
Indicator
QNRX
AIXI
Relative Strength Index (RSI) 42.32 34.99
Support Level $11.48 $0.64
Resistance Level $15.45 $0.71
Average True Range (ATR) 2.60 0.08
MACD -1.05 0.01
Stochastic Oscillator 11.54 7.92

Price Performance

Historical Comparison
QNRX
AIXI

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About AIXI XIAO-I Corporation

XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.

Share on Social Networks: